Evaluating efficacy and safety of differential therapy with atorvastatin, fenofibrate and their combination in patients with type 2 diabetes
Statins are the basis pharmacotherapy in the treatment of atherogenic dyslipidemia in diabetes mellitus (DM) type 2. [1, 3] For dyslipidemia with high triglyceride (TG) level and low concentrations of high density lipoprotein cholesterol (HDL-C) fibrates are traditionally used. [2, 4] Russia has lim...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2015-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/295 |